Form 4: Blueprint Medicines COO Christina Rossi Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Christina Rossi, Chief Operating Officer of Blueprint Medicines Corp, sold shares of common stock on May 5, 2025, under a pre-arranged trading plan.
Summary
- Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp, reported the sale of common stock on May 5, 2025.
- The sales were executed under a trading plan adopted on August 27, 2024, in accordance with Rule 10b5-1.
- A total of 2,274 shares were sold in multiple transactions at prices ranging from $100.32 to $104.05.
- Following the reported transactions, Rossi directly owns 66,992 shares of Blueprint Medicines Corp.
- The reporting person has undertaken to provide full information regarding the number of shares sold at each separate price within the specified ranges upon request.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock sales by an insider under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The information is relevant to investors as it provides transparency regarding the trading activities of company insiders.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of adoption of the Rule 10b5-1 trading plan |
| 05/05/2025 | Date of the reported stock sales |
| 05/07/2025 | Date of signature on the Form 4 filing |
Keywords
Form 4, Blueprint Medicines, Christina Rossi, BPMC, Stock Sale, 10b5-1 Trading Plan, Chief Operating Officer, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.